Projects funded by the NCN
Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strategy for experimental anticancer therapy.
2025/57/B/NZ7/02468
Keywords:
1,3-selenazole-2-on derivatives selenium self-emulsifying drug delivery systems cancer
Descriptors:
- NZ7_07:
- NZ1_09:
- NZ3_02:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 29 - announced on 2025-03-17
Amount awarded: 3 073 640 PLN
Project start date (Y-m-d): 2026-02-02
Project end date (Y-m-d): 2030-02-01
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.